Price index of veterinary APIs

The price index of veterinary APIs published by the China Veterinary Drug and Feed Trade Center was 62.54-62.57-62.59-62.71 respectively for the four weeks of this month (June 5th-27th).

The veterinary APIs market ushered in differentiation in June, with most mainstream categories running steadily while the prices of some individual categories rebounded and a few categories continued to rebound strongly under the influence of supply compression. In early July, most of the mainstream categories were mainly operating to maintain stability,while Tylocin continued its previous trend and the price rose sharply; In the middle of the month, penicillin potassium industrial salt,erythromycin thiocyanate,lincomycin hydrochloride and other API products for both human and animal use performed more relatively well, and the main business increased; In late June,affected by the news and expectations of summer shutdown and maintenance, the market prices of doxycycline hydrochloride and other categories increased steadily.

In a buyer's market, demand is the fundamental driving force of market price quotations. However, the market strategy of the upstream supply side will also play an important role in the market changes. At the Veterinary Drugs Conference recently held in Shenzhen and CPHI in Shanghai, it is originally predicted that there might be active market dynamics after the event, but there were no expected fluctuations in the last week of June.

The future market trend will closely depend on the interaction between supply and demand, especially the strategic adjustment of upstream factories and the actual recovery of downstream demand.

The average price of florfenicol market rose slightly. On the 12th, the average price was CNY191/kg, up 0.53% MoM. The supply from mainstream factories was relatively stable, the supply of low-priced goods in the market reduced, and the spot position remained generally positive.

Due to the significant cost reductions caused by the adoption of new processing technology, the competition among manufacturers has entered a new platform period, and the subsequent upsurge in prices will be difficult to support by reliable factors.

On the 26th of this month, the average market price of Doxycycline Hydrochloride was CNY338/kg, up 0.90% MoM, with a rebound of 6.96% from the low. After nearly a month of silence, the market transaction price was slightly pulled up again. Upstream manufacturers to control shipments is the main factor in this sustained rebound. In the third quarter, mainstream manufacturers will overhaul their production during the high temperature season; the price strategy will continue, and the pig industry will continue to improve; all these factors will push doxycycline hydrochloride to continue its previous inertia and maintain an upward trend.

In the middle of June, the prices of tylosin tartrate and tilmicosin and other related products were raised. With the recent significant rise in domestic hog prices, tylosin tartrate and tilmicosin, as veterinary APIs for "pig farming", have shown a stabilizing trend. After a long time of substantial decline, under the influence of the factors such as cost, profits and price-supporting willingness, tylosin tartrate and other categories have been difficult to have more space for further decline, as the market is still in the bottoming out and the wandering stage. With the recovery of the pig farming industry and the steady demand for such products, the market price of these APIs will be firmly supported.

Following CPHI China held on 19-21 June, the amoxicillin market is stable, market news has been released, recent trade is on wait-and-see and reluctant to sell, and the market price index remains stable and strong.

Vitamin prices in June maintained a stable position, and most of the product prices did not show signs of significant fluctuations, but there was differentiation within the market. For vitamin B1, D3 and other categories, the factories hold more willingness to raise prices, and prices are going firmer. The Vitamin E quotation was strong by the impact of the market information; Vitamin C prices were raised by mainstream factories. End-users are more likely to take a conservative strategy and lack large-scale stocking willingness.

It is expected that the market will continue to be affected by the adjustment of supply and demand, and find a balance between the price increase of the supply side and the weak demand from downstream consumers.

The market market price index remained stable and firm, with a strong wait-and-see mood at the terminal. The replenishment was mainly based on demand, and mainstream factories released positive news, such as the suspension of reporting and price increases. Market attention increased, and traders were reluctant to sell and wait to see.

Market prices in June were firm, and export inquiries were relatively more active. On June 24, the quotation of Vitamin E was CNY74/kg, up 25.4% from the beginning of the year. The increase is mainly affected by multiple reasons, such as the intensive shutdown and overhaul of leading enterprises, the sharp rise in global shipping freight and the rebound of prices due to oversold prices.

DSM plant had started a 2-month production shutdown for maintenance in late May.

Zhejiang Medicine (ZMC) has been scheduled for a two-month production shutdown for maintenance from mid-July, and the quotation for Vitamin E products has been suspended worldwide.

NHU Shandong plant is scheduled for maintenance from early July to early September.

The raw materials cost of Calcium pantothenate has increased, and there is a trend of stopping the decline at present. Although the main factories released their willingness to stop quotation and support prices, the market had a strong wait-and-see mood, and the market price index fluctuated and remained stable.

Recently, raw material prices have been rising, the domestic mainstream factories have expressed their willingness to maintain prices. Some manufacturers stopped reporting and signing, the market transactions have slightly risen, attracting high market attention.

The overall trading atmosphere of the domestic amino acid market is flat, and the terminal is mainly replenished as needed. Lysine and threonine continued to rise slightly, 98.5% lysine was in short supply, and manufacturers had a strong willingness to raise prices. The prices of methionine, valine and tryptophan are temporarily stable.

NHU and CUC plan to start routine maintenance in Q3, and it is expected that the price of methionine will remain weak and stable in the short term. The demand for non-fundamental amino acids is sluggish, and the price is low.

The state encourages the reduction and substitution of soybean meal in the feed industry, which will stimulate the demand for the non-fundamental amino acids.

Meihua Baicheng's 600,000 tons/a lysine project participated in an environmental impact assessment (EIA).

NHU Shandong methionine plant will be overhauled for 6-7 weeks in the third quarter.

Ningxia CUC (methionine producer) plans to suspend production for 4-5 weeks in Q2.

Evonik's methionine plant upgrade is expected to be completed by the end of June.

Heilongjiang XMXYG Biochemical plans to switch threonine to valine production in Q3.

Florfenicol API and medicated premix are manufactured and processed using state-of-the-art technology. They are indicated for the treatment of bacterial diseases and respiratory infections in poultry.

Product link:

Florfenicol premix:

Florfenicol API: 

(50mg/g Tylvalosin Tartrate)

Tylvalosin Tartrate (Acetylisovaleryltylosin Tartrate)is used for the treatment of mycoplasma infection and spirochete pullorum and other sensitive bacteria in swine and poultry.
 
Tylvalosin was approved by the European Union in 2004,and approved by USA FDA in 2012.
 
For more information,click the below link: